| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
More...
| ||||||||||||||||||||||||||||||||||||
| << Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >> | ||||||||||||||||||||||||||||||||||||
| Results 1 - 17 of 1441 | ||||||||||||||||||||||||||||||||||||
More
-
UPDATE 3-GTx prostate cancer drug needs more study; shares hit
Research ) prostate cancer drug did not yield promising results, potentially delaying its evaluation by U.S. health regulators and sending the biotechnology company's shares down as much as 14 perc...
-
FX Real Estate and Entertainment Inc. Chairman Robert F.X. Sillerman Exercises Rights in Pending...
FX Real Estate and Entertainment Inc. , announced today that Robert F.X. Sillerman, the Company's Chairman and Chief Executive Officer, has exercised all of the rights he received in the Company's pending rights offering, resulting in his purchase of 3,037,265 shares at a price of $10 per share.